 |
Exemestane |
|---|---|
| Trade Name | Aromasin |
| Orphan Indication | Advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy |
| USA Market Approval | USA |
| USA Designation Date | 1991-09-19 00:00:00 |
| Sponsor | Pharmacia & Upjohn;7000 Portage Road, Mail Stop: 0636-298-113;Kalamazoo, Michigan, 49001 |
